Author

R. Herati

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Organism:virus· 1

Frequent Co-Authors

B. M. Dcosta· 2 shared H. Zhou· 2 shared M. I. Samanovic· 2 shared M. J. Mulligan· 2 shared N. R. Landau· 2 shared T. Tada· 2 shared A. Cornelius· 1 shared C. G. Pfeifer· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. M. Dcosta

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies

T. Tada, H. Zhou, B. M. Dcosta, M. I. Samanovic, V. Chivukula, R. Herati, S. R. Hubbard, M. J. Mulligan, N. R. Landau

The paper assesses Omicron's resistance to vaccine and monoclonal antibody neutralization, finding boosters improve efficacy but existing therapies are largely ineffective.

bioRxiv · Dec 28, 2021Immunology

Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection

T. Tada, H. Zhou, B. M. Dcosta, M. I. Samanovic, A. Cornelius, R. Herati, M. J. Mulligan, N. R. Landau

This study evaluates neutralization of SARS-CoV-2 Mu and C.1.2 variants by vaccine-elicited and convalescent antibodies, finding that vaccine-induced responses remain protective despite partial resistance.

bioRxiv · Oct 19, 2021Immunology

Mutation of an L-Type Calcium Channel Gene Leads to a Novel Human Primary Cellular Immunodeficiency

F. Fenninger, S. R. Stanwood, C.-J. Lu, C. G. Pfeifer, O. Khan, N. D. Romberg, R. Herati, E. J. Wherry, K. C. O'Boyle, S. E. Henrickson, K. Maurer, M. A. Ruffner, W. A. Jefferies, K. E. Sullivan

This study identifies a mutation in the Cav1.4 gene causing a primary immunodeficiency with immune dysfunction and recurrent infections.

bioRxiv · Dec 4, 2019 · PreprintImmunology